The cytotoxicity of hexahydrocurcumin and its effect on the cell cycle in human colorectal cancer cells SW480 has been studied for the first time. The compound, extracted from Zingiber officinale, was shown to be cytotoxic to colorectal cancer cells. Treatment of SW480 cells with hexahydrocurcumin (100 µM) resulted in a massive accumulation of the cells in the G1/G0 phase of the cell cycle. The cytotoxic effect of hexahydrocurcumin may prove useful in cancer prevention.
Ginger (Zingiber officinale) is a common condiment for various foods and beverages. The underground stem or rhizome of this plant has been used as a medicine in Asian, Indian, Chinese and Arabic herbal traditions since ancient time [1a,1b] . The non-volatile pungent ingredients from ginger include gingerol, shoagol, and zingerone. Recently, several population-based studies showed that people in South East Asian countries have a much lower risk of colon, gastrointestinal, prostate, breast, and other cancers than European and American countries [1c] . It is believed that constituents of their dietary supplements may play an important role in this protection.
In both in vitro and in vivo experimental carcinogenesis, curcumin derivatives have been shown to possess cancer preventive activities [1b,1d-1g] . These compounds are known to have the ability to suppress the transformative, hyperproliferative, and inflammatory processes of carcinogenesis. However, little study has been made on the anti-proliferative effect of hexahydrocurcumin (1) on human colorectal cancer SW480 cells.
Hexahydrocurcumin (1), (5S)-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptan-3-one [1h], suppresses the activity of nitric oxide synthase through down-regulation of IκB kinase and NFκB activation in macrophages [1i] . Different natural products, such as [6]-gingerol, [10]-gingerol and [6]-shogaol have been found to induce cell death in malignant cells [1d,1f,1h] . To elucidate the cytotoxic mechanism of hexahydrocurcumin (1), experiments were performed to examine the effect of 24 h incubation with 1 on the viability of SW480 cells. Colon cancer cells were treated with 0-100 μM for 24 h before the trypan blue method was performed [2a] . At 50-100 μM Next, we analyzed the DNA contents of hexahydrocurcumin (1)-treated SW480 cells by flow cytometry. Data were analyzed with ModFit LT software and were displayed as the percentage of each cell cycle phase. The representative result depicting the effect of treatment with 1 for 24 h on the cell cycle phase distribution in SW480 cells is shown in Figure B . Incubation with 50 and 100 μM 1 for 24 h resulted in the accumulation of cells in the G1/G0 phase (65.4 and 76.8%, respectively) compared with that in the control (45.4%). It is suggested that this agent either induced the blockage of G1/S transition or G1 arrest. Collectively, our study provides the first evidence that 1 selectively accumulates and elicits G1 phase cell cycle arrest on colorectal cancer cells. These results suggest that hexahydrocurcumin (1) is appropriate for either clinical trial or as an anti-cancer agents in colorectal cancer.
Experimental

Reagents and materials:
The reagents for cell culture were from Gibco (Gaithersburg, MD, USA). The other reagents were obtained from Sigma (St. Louis, MO, USA).
Purification of hexahydrocurcumin from Z. officinale:
The rhizomes of Z. officinale (ginger) were purchased from a local market in Kaohsiung, Taiwan, in July 2006, and were identified by Dr Yen-Ray Hsui, Taiwan Forestry Research Institute, Taipei, Taiwan. A voucher specimen (Hsui-Zo-1) was deposited at Fooyin University.
Extraction and isolation:
The rhizomes (25.6 kg) were chipped, air-dried, and extracted repeatedly with CHCl 3 (50 L × 4) at room temperature. Hexahydrocurcumin (1) was isolated as described previously [2b] . In brief, the combined CHCl 3 extracts (896.5 g) were separated into 20 fractions by CC on silica gel (3.8 kg, 70-230 mesh) with gradients of n-hexane/CHCl 3 . Fr. 15 (117.1 g), eluted with CHCl 3 /MeOH (30:1), was subjected to silica gel CC (CHCl 3 /MeOH mixtures) and yielded pure hexahydrocurcumin (1) (251 mg). This compound was identified by spectroscopic data analysis and comparison with literature values.
Cell culture: The SW480 cells, obtained from the American Type Culture Collection, were cultured in Dulbecco's modified Eagle's medium, supplemented with 10% heat-inactivated fetal calf serum, 100 units/mL penicillin and 100 μg/mL streptomycin. Cells were kept at 37°C in 5% CO 2 -containing humidified air.
Cell viability assay:
Cell viability was determined by the trypan blue exclusion (TBE) method [1f] . Briefly, 10 μL of 4% trypan blue was added to 90 μL of cell suspension, followed by examination with a hemocytometer under an inverted microscope. Cells which excluded the dye were considered viable and the data were expressed as a percentage of that of the corresponding control group.
Cell cycle analysis:
This determination was based on the measurement of the DNA content of nuclei labeled with PI [3a,3b] . Adherent and floating cells were pooled, washed with physiological saline, then fixed in saline-methanol (1:2, v/v) solution and maintained at 4°C for over 18 h. Following 2 more washes with saline, the cell pellet was stained with the fluorescent probe solution containing saline, 40 μg/mL propidium iodide and 40 μg/mL DNasefree RNase A for 30 min at room temperature in the dark. Cells were then analyzed using an FACS-Calibur cytometer (Becton Dickinson, San Jose, CA, USA) with excitation at 488 nm, with gating out of doublets and clumps using pulse processing and collection of fluorescence emission above 620 nm. The percentage of cells undergoing DNA damage was obtained from the percentage of cells in the distinct subdiploid region of the DNA distribution histograms. The experiments were repeated 3 times.
Statistics: Data are presented as means ± standard deviation (SD) and were analyzed using one-way ANOVA with Scheffe′s test. A p value of less than 0.05 was considered as statistically significant.
